Latest news & articles

Latest news
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, led […]
New research funding may allow those with type 1 diabetes to make insulin again
Research

New research funding may allow those with type 1 diabetes to make insulin again

JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.
Research

Regenerating damaged beta cells in type 1 diabetes ꟷ new funding announced.

JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Research breakthrough shows that antivirals can delay T1D progression
Research

Research breakthrough shows that antivirals can delay T1D progression

A new study suggests that giving antivirals shortly after a type 1 diabetes (T1D) diagnosis may preserve the body’s ability to produce insulin. Recent results from a clinical trial published in the prestigious Nature journal have suggested that administering the antivirals pleconaril and ribavirin can preserve beta cell function in children and teenagers recently diagnosed […]
Type 1 diabetes screening pilot rolls out in primary school for the first time
Research

Type 1 diabetes screening pilot rolls out in primary school for the first time

This World Diabetes Day, on Tuesday 14th November, students from kindergarten and year 4 at Inaburra School in Sydney’s south participated in screening to detect type 1 diabetes (T1D). This is part of the JDRF-funded Australian Type 1 Diabetes National Screening Pilot, a research project looking to identify early-stage T1D in childhood. It was the first […]
Teplizumab shown to slow down type 1 diabetes in those newly diagnosed
Research

Teplizumab shown to slow down type 1 diabetes in those newly diagnosed

Research findings have just been released for the PROTECT clinical trial which tested whether the disease-modifying therapy Teplizumab is able to delay type 1 diabetes (T1D) progression in those newly diagnosed. What is Teplizumab?  Teplizumab is a therapy which has been shown to delay the progression from an early stage of T1D (Stage 2) to […]
Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient
Research

Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient

JDRF Australia’s Career Support and Travel Grants for domestic and international travel are designed to support the next generation of type 1 diabetes (T1D) researchers. They allow early to mid-career researchers and allied health professionals to gain new skills, exchange knowledge, and establish connections and collaborations. We recently spoke to David de George, PhD student […]
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Research

Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop

Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
Talking with Dr Ying Wong, Career Support and Travel Grants Recipient
Researchers

Talking with Dr Ying Wong, Career Support and Travel Grants Recipient

JDRF’s Career Support and Travel Grants for domestic and international travel are designed to support the next generation of type 1 diabetes (T1D) clinical care by enabling early to mid-career researchers and allied health professionals to gain new skills, exchange knowledge, and establish connections and collaborations.   We recently spoke to Dr Ying Wong, postdoctoral research […]
JDRF announces funding for clinician-researchers dedicated to type 1 diabetes 
Researchers

JDRF announces funding for clinician-researchers dedicated to type 1 diabetes 

The 2022 recipients of JDRF’s Rebecca Davies Clinician Research Fellowship have today been announced, awarded to Dr Jennifer Snaith from St Vincent’s Hospital and Dr Keely Bebbington from the University of Western Australia.    The funding provided by the Fellowship is designed to create dedicated research time for active clinicians who are pursuing a career in […]
How You Can Help Make Type 1 Diabetes Research a Reality 
Research

How You Can Help Make Type 1 Diabetes Research a Reality 

JDRF has an ambitious vision — a world without type 1 diabetes (T1D). We are the biggest funder of type 1 diabetes research globally and in Australia. In order to achieve this with such a complex autoimmune disease, we must take a strategic, multi-level and collaborative approach to research. JDRF has embarked on an extensive […]